In this episode Michael and Justin chat with Nat Turner, CEO and co-founder of Flatiron Health, a mission focused, NYC headquartered technology firm dedicated to improving treatment for cancer patients and significantly accelerating cancer research.
Nat discusses his chance meeting with college friend and Flatiron, co-founder Zach Weinberg (Zach was unable to join us, but will be on a follow-up podcast), their recent 2.1B acquisition by Roche Group as well as their failures, pivots, and all around experiences since their early days at Wharton.
Zeroing in on their dynamic over the years and how they grew step by step as entrepreneurs and co-investors in numerous start-ups, Nat shares great stories of continual learning and adjustments throughout their journey, which shines a light on this duos maturity and largesse as true partners and friends.
Nat Turner is co-founder and CEO of Flatiron Health, where he oversees all initiatives across provider solutions, clinical oncology, business development, sales operations, legal and other corporate functions.
Before co-founding Flatiron Health, Nat was co-founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry’s first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010.
Prior to Invite Media, Nat started numerous internet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Clover Health, Color Genomics, Doctor Evidence, Gravie, Notable Labs, Oscar and Quartet Health.
Nat earned a Bachelor of Science degree cum laude in economics with concentrations in entrepreneurship and marketing from the Wharton School at the University of Pennsylvania.